BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18431247)

  • 1. Occult hepatitis B is not necessarily an infection.
    Shorbagi A; Bayraktar Y
    J Clin Gastroenterol; 2008 Oct; 42(9):1064-5. PubMed ID: 18431247
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
    Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"?
    Bréchot C; Thiers V; Kremsdorf D; Nalpas B; Pol S; Paterlini-Bréchot P
    Hepatology; 2001 Jul; 34(1):194-203. PubMed ID: 11431751
    [No Abstract]   [Full Text] [Related]  

  • 4. Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors.
    Allain JP; Sarkodie F; Candotti D; Opare-Sem O
    Transfusion; 2005 Jun; 45(6):1039-40. PubMed ID: 15935007
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
    J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progresses in the molecular diagnosis of hepatitis B viral infection].
    Panait M; Oprişan G; Codiţă I
    Bacteriol Virusol Parazitol Epidemiol; 2008; 53(1):5-12. PubMed ID: 19241991
    [No Abstract]   [Full Text] [Related]  

  • 7. Ascertaining the prevalence of occult hepatitis B virus infection in voluntary blood donors: a study from Central India.
    Punde RP; Bhargava A; Varshney S; Pathak N; Shrivastava M; Mishra PK
    Indian J Pathol Microbiol; 2011; 54(2):408. PubMed ID: 21623110
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylaxis of hepatitis B virus recurrence after liver transplantation.
    Testino G; Borro P; Sumberaz A
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):139-41. PubMed ID: 19565040
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatitis B virus: a better knowledge of its structure and variations in the expression of the viral disease].
    Bréchot C
    Gastroenterol Clin Biol; 1984; 8(8-9):641-5. PubMed ID: 6386590
    [No Abstract]   [Full Text] [Related]  

  • 10. Test for hepatitis B virus infection with radical immunoassay and real-time PCR: which method is the gold standard?
    Xuan SY; Xin YN; Zhong YD; Zheng MH; Guan HS
    J Hepatol; 2009 Jan; 50(1):211-2; author reply 213. PubMed ID: 19004517
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis of hepatitis B virus infection through serological and virological markers.
    Kao JH
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):553-62. PubMed ID: 19072403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between hepatitis B virus DNA levels and liver histology: is the controversy because of paucity of data?
    Verma S; Thuluvath PJ
    J Clin Gastroenterol; 2007 Apr; 41(4):339-42. PubMed ID: 17413597
    [No Abstract]   [Full Text] [Related]  

  • 13. Viral hepatitis in HIV infection.
    Leiner S
    N Engl J Med; 2007 Jul; 357(1):90; author reply 91. PubMed ID: 17615640
    [No Abstract]   [Full Text] [Related]  

  • 14. [Occult hepatitis B virus infection in chronic viral hepatitis patients with non-A to E hepatitis virus infection].
    Shang QH; Yu JG; Xu CZ; An Y; Liu FY; Sun SC; Zhang GS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):440-2. PubMed ID: 19544639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti-HBc screening.
    Allain JP
    Vox Sang; 2007 Apr; 92(3):254-7. PubMed ID: 17348876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of hepatitis B markers.
    Lodenyo H
    Trop Gastroenterol; 2000; 21(1):12-3. PubMed ID: 10835953
    [No Abstract]   [Full Text] [Related]  

  • 17. [Screening for hepatitis B].
    Krogsgaard K
    Ugeskr Laeger; 2002 Jan; 164(2):159-62. PubMed ID: 11831078
    [No Abstract]   [Full Text] [Related]  

  • 18. Occult hepatitis B virus infection: a hidden menace?
    Conjeevaram HS; Lok AS
    Hepatology; 2001 Jul; 34(1):204-6. PubMed ID: 11431752
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of markers of hepatitis viral infection in the tissue of bile duct carcinoma.
    Liu HB; Qian ZY; Wang BS; Tong SX
    Chin Med J (Engl); 2008 Jun; 121(12):1143-4. PubMed ID: 18706237
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection.
    Zaaijer HL; Torres P; Ontañón A; Ponte LG; Koppelman MH; Lelie PN; Hemert FJ; Boot HJ
    J Med Virol; 2008 Aug; 80(8):1344-9. PubMed ID: 18551607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.